Tactile Systems Technology Inc (TCMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Tactile Systems Technology Inc (TCMD) has a cash flow conversion efficiency ratio of -0.002x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-339.00K) by net assets ($217.87 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See TCMD defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Tactile Systems Technology Inc - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Tactile Systems Technology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Tactile Systems Technology Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Tactile Systems Technology Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FinVolution Group
F:PP3
|
0.028x |
|
Western Copper and Gold Corp
TO:WRN
|
-0.004x |
|
Danske Andelskassers Bank A/S
CO:DAB
|
-0.112x |
|
Consultatio SA
BA:CTIO
|
-0.228x |
|
Linkage Software Co Ltd
SHG:688588
|
0.037x |
|
Clarity Pharmaceuticals Ltd
AU:CU6
|
-0.205x |
|
Shandong Rike Chemical
SHE:300214
|
0.022x |
|
BridgeBio Oncology Therapeutics, Inc.
NASDAQ:BBOT
|
-0.096x |
Annual Cash Flow Conversion Efficiency for Tactile Systems Technology Inc (2013–2025)
The table below shows the annual cash flow conversion efficiency of Tactile Systems Technology Inc from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see TCMD market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $218.90 Million | $42.81 Million | 0.196x | +4.19% |
| 2024-12-31 | $216.60 Million | $40.66 Million | 0.188x | +1.37% |
| 2023-12-31 | $193.64 Million | $35.85 Million | 0.185x | +331.53% |
| 2022-12-31 | $121.40 Million | $5.21 Million | 0.043x | +109.12% |
| 2021-12-31 | $128.23 Million | $2.63 Million | 0.021x | -8.39% |
| 2020-12-31 | $124.75 Million | $2.79 Million | 0.022x | +0.47% |
| 2019-12-31 | $112.59 Million | $2.51 Million | 0.022x | -77.91% |
| 2018-12-31 | $89.27 Million | $9.01 Million | 0.101x | +75.19% |
| 2017-12-31 | $72.79 Million | $4.19 Million | 0.058x | -51.16% |
| 2016-12-31 | $59.64 Million | $7.03 Million | 0.118x | +136.88% |
| 2015-12-31 | $27.28 Million | $1.36 Million | 0.050x | +223.86% |
| 2014-12-31 | $24.66 Million | $-991.00K | -0.040x | -110.02% |
| 2013-12-31 | $22.21 Million | $-425.00K | -0.019x | -- |
About Tactile Systems Technology Inc
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression dev… Read more